£6.5M
The financing round was backed by Maven Capital Partners, YFM Equity Partners, Triple Point Ventures, and regional funds to support US growth.
Biorelate
Biorelate provides an artificial intelligence platform that curates biomedical data to support drug discovery.
£6.8MTotal raised
Biorelate curates biomedical knowledge using a proprietary artificial intelligence platform to assist pharmaceutical and life sciences organisations with drug discovery. The company operates from the UK and works with global enterprises.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Current assets
Members only
Cash, assets and headcount from Biorelate's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
DJ
Daniel Jamieson
CEO
Daniel brings scientific and entrepreneurial experience, having worked as a bioinformatician at Pfizer and Merck before founding Biorelate.
LinkedInDJ
Dan Jamieson
founder and CEO
Dan brings scientific and entrepreneurial experience, having founded Biorelate after working as a bioinformatician at Pfizer and Merck.
Investors
- £6.5M
- £300KInnovate UKLead
Funding history
£300K
The funding will support a joint project combining deep text mining and sparse data solutions.